全球基因分析市場

到 2030 年，全球基因分析市場規模將達到 165 億美元

全球基因檢測市場規模預計在2024年為116億美元，預計到2030年將達到165億美元，在分析期內（2024-2030年）的複合年成長率為6.1%。試劑和套件是本報告分析的細分市場之一，預計其複合年成長率為6.6%，到分析期結束時規模將達到94億美元。設備細分市場在分析期間內的複合年成長率預計為4.7%。

美國市場規模估計為 32 億美元，中國市場預期複合年成長率為 9.6%

美國基因分析市場規模預計2024年達到32億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到34億美元，在2024-2030年的分析期間內，複合年成長率為9.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為2.9%和6.0%。在歐洲，預計德國市場的複合年成長率為4.0%。

全球基因分析市場—主要趨勢與促進因素摘要

為什麼基因分析會徹底改變醫療保健和科學研究？

基因分析透過提供關於DNA序列、基因突變和疾病易感性的關鍵見解，徹底改變了醫療保健、農業和生物醫學研究。次世代定序(NGS)、聚合酵素鏈鎖反應(PCR) 和微陣列技術的進步，使研究人員能夠以前所未有的精度和速度解讀遺傳訊息。這些技術透過識別遺傳疾病、早期檢測癌症以及個人化醫療方法，徹底改變了患者照護和疾病管理。

除了醫療保健領域，基因分析在法醫學、演化生物學和農業領域也扮演著至關重要的角色。在法醫學調查中，DNA分析可以增強破案能力；而在農業領域，基因分析有助於培育產量抗病作物。此外，直接面對消費者的基因檢測日益普及，透過提供關於血統、健康風險和遺傳特徵的洞見，推動了市場成長。隨著基因分析應用的不斷擴展，多個行業對高通量測序和生物資訊解決方案的需求也在成長。

哪些產業正在推動基因分析的需求？

醫療保健產業是基因分析技術的最大消費領域，利用基因組學洞察進行疾病風險評估、精準醫療和生殖健康篩檢。腫瘤學是重點關注領域，基因檢測可根據患者獨特的基因圖譜指導癌症的標靶治療。此外，罕見疾病基因篩檢、產前檢測和藥物基因組學顯著改善了早期診斷和治療計劃。

在農業領域，基因分析在作物改良和牲畜育種中發揮著至關重要的作用。透過識別與產量、抗病性和環境適應性相關的基因，研究人員正在開發基因最佳化的作物，以應對全球糧食安全挑戰。生物技術和製藥產業也利用基因分析進行藥物研發、基因治療研究和微生物組分析。隨著測序技術和人工智慧驅動的生物資訊學的不斷進步，基因分析對於研究和商業應用變得至關重要。

基因分析領域有哪些最新創新？

基因分析技術的創新顯著提高了定序的準確性、資料處理速度和成本效益。單細胞定序的發展使科學家能夠在細胞層面分析基因突變，從而改善癌症診斷和神經科學研究。此外，人工智慧和機器學習在生物資訊學中的融合正在加速基因組註釋、變異解釋和疾病風險預測。

PacBio 和 Oxford Nanopore 等長讀長定序技術進一步擴展了基因分析的能力，使其能夠更全面地洞察複雜的基因組結構。基於 CRISPR 的基因編輯和合成生物學的進展也補充了基因分析，使研究人員能夠高精度地修改 DNA 序列。隨著基因研究的不斷發展，這些創新有望推動下一代診斷、治療和農業領域的突破。

哪些因素推動了基因分析市場的成長？

基因分析市場的成長受到多種因素的推動，包括精準醫療需求的不斷成長、NGS技術的普及率不斷提高，以及在農業和生物技術領域的應用不斷拓展。 DNA定序成本的下降使得基因分析更加便捷，從而推動了大規模群體基因組學計劃和個人化醫療保健的發展。此外，政府和私人對基因組研究的投入也加速了技術進步和商業性應用。

遺傳疾病和癌症的日益流行，進一步推動了對基因篩檢和早期診斷的需求。隨著消費者尋求了解自身健康狀況、家族史和生活方式傾向，直接面對消費者的基因檢測市場也不斷擴大。此外，雲端運算和人工智慧在基因數據分析中的融合正在提高效率和擴充性，從而進一步支持市場擴張。隨著基因分析成為多個行業的重要工具，其應用預計將持續成長，塑造基因組學主導的創新和個人化醫療的未來。

部分

產品（試劑/套件、設備、軟體）、檢測（基因預測、載體、產前/新生兒、疾病診斷、藥物基因組學等）、技術（下一代定序技術、即時PCR系統技術、其他技術）、應用（癌症、遺傳疾病、循環系統疾病、罕見疾病、感染疾病等）、終端用途（醫院、研發實驗室、診斷中心等）

受訪公司範例

• Autumn DNA
• Blueprint Genetics
• Caris Life Sciences
• Color Health, Inc.
• Coriell Life Sciences
• deCODE genetics
• Exact Sciences Corporation
• Foundation Medicine
• Fulgent Genetics
• Gene by Gene
• Genomic Life
• Guardant Health
• Illumina, Inc.
• Invitae Corporation
• Myriad Genetics
• NeoGenomics Laboratories
• Newtopia Inc.
• Qiagen NV
• Sophia Genetics
• Thermo Fisher Scientific

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有遵循典型的 LLM 或特定於行業的 SLM查詢，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Genetic Analysis Market to Reach US$16.5 Billion by 2030

The global market for Genetic Analysis estimated at US$11.6 Billion in the year 2024, is expected to reach US$16.5 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$9.4 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.2 Billion While China is Forecast to Grow at 9.6% CAGR

The Genetic Analysis market in the U.S. is estimated at US$3.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.4 Billion by the year 2030 trailing a CAGR of 9.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 6.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Genetic Analysis Market - Key Trends & Drivers Summarized

Why Is Genetic Analysis Revolutionizing Healthcare and Scientific Research?

Genetic analysis has transformed healthcare, agriculture, and biomedical research by providing critical insights into DNA sequences, genetic variations, and disease predisposition. Advances in next-generation sequencing (NGS), polymerase chain reaction (PCR), and microarray technologies have enabled researchers to decode genetic information with unprecedented accuracy and speed. These techniques allow for the identification of hereditary diseases, early cancer detection, and personalized medicine approaches, revolutionizing patient care and disease management.

Beyond healthcare, genetic analysis plays a crucial role in forensic science, evolutionary biology, and agriculture. In forensic investigations, DNA profiling has enhanced crime-solving capabilities, while in agriculture, genetic analysis has facilitated the breeding of high-yield, disease-resistant crops. The increasing accessibility of direct-to-consumer (DTC) genetic testing has also driven market growth, allowing individuals to gain insights into their ancestry, health risks, and inherited traits. As the applications of genetic analysis continue to expand, the demand for high-throughput sequencing and bioinformatics solutions is rising across multiple industries.

Which Industries Are Driving the Demand for Genetic Analysis?

The healthcare sector is the largest consumer of genetic analysis technologies, leveraging genomic insights for disease risk assessment, precision medicine, and reproductive health screening. Oncology has been a primary focus area, with genetic tests guiding targeted cancer therapies based on a patient’s unique genetic profile. Additionally, genetic screening for rare diseases, prenatal testing, and pharmacogenomics has significantly improved early diagnosis and treatment planning.

In agriculture, genetic analysis is playing a pivotal role in crop improvement and livestock breeding. By identifying genes associated with yield, disease resistance, and environmental adaptability, researchers are developing genetically optimized crops to address global food security challenges. The biotechnology and pharmaceutical industries also rely on genetic analysis for drug discovery, gene therapy research, and microbiome analysis. With continuous advancements in sequencing technologies and AI-driven bioinformatics, genetic analysis is becoming an integral part of research and commercial applications.

What Are the Latest Technological Innovations in Genetic Analysis?

Technological innovations in genetic analysis have significantly enhanced sequencing accuracy, data processing speed, and cost-effectiveness. The development of single-cell sequencing has enabled scientists to analyze genetic variations at the cellular level, improving cancer diagnostics and neuroscience research. Additionally, the integration of AI and machine learning in bioinformatics has accelerated genome annotation, variant interpretation, and disease risk prediction.

Long-read sequencing technologies, such as PacBio and Oxford Nanopore, have further expanded the capabilities of genetic analysis by providing more comprehensive insights into complex genomic structures. Advances in CRISPR-based gene editing and synthetic biology are also complementing genetic analysis, allowing researchers to modify DNA sequences with high precision. As genetic research continues to evolve, these innovations are expected to drive the next generation of diagnostic, therapeutic, and agricultural breakthroughs.

What Factors Are Fueling the Growth of the Genetic Analysis Market?

The growth in the genetic analysis market is driven by several factors, including increasing demand for precision medicine, rising adoption of NGS technologies, and expanding applications in agriculture and biotechnology. The declining cost of DNA sequencing has made genetic analysis more accessible, enabling large-scale population genomics projects and personalized healthcare initiatives. Additionally, government funding and private investments in genomic research have accelerated technological advancements and commercial adoption.

The growing prevalence of genetic disorders and cancer has further increased the need for genetic screening and early diagnostics. The direct-to-consumer genetic testing market is also expanding, as consumers seek insights into their health, ancestry, and lifestyle predispositions. Moreover, the integration of cloud computing and AI in genetic data analysis has improved efficiency and scalability, driving market expansion. As genetic analysis becomes an essential tool across multiple industries, its adoption is expected to continue growing, shaping the future of genomics-driven innovation and personalized medicine.

SCOPE OF STUDY:

The report analyzes the Genetic Analysis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents & Kits, Instruments, Software); Test (Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, Other Tests); Technology (Next-Generation Sequencing Technology, Real-Time PCR System Technology, Other Technologies); Application (Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application, Other Applications); End-Use (Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Autumn DNA
• Blueprint Genetics
• Caris Life Sciences
• Color Health, Inc.
• Coriell Life Sciences
• deCODE genetics
• Exact Sciences Corporation
• Foundation Medicine
• Fulgent Genetics
• Gene by Gene
• Genomic Life
• Guardant Health
• Illumina, Inc.
• Invitae Corporation
• Myriad Genetics
• NeoGenomics Laboratories
• Newtopia Inc.
• Qiagen N.V.
• Sophia Genetics
• Thermo Fisher Scientific

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Genetic Analysis - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Explosion of Genomic Data and Falling Sequencing Costs Drive Rapid Expansion of Genetic Analysis Applications
  • Increased Adoption of Genetic Testing for Personalized Medicine Fuels Growth in Diagnostic and Predictive Genomics
  • Expansion of Population-Scale Genomics Programs Spurs Demand for High-Throughput Genetic Analysis Platforms
  • Wider Use of NGS, qPCR, and Microarrays Across Research and Clinical Applications Broadens Technology Adoption
  • Rising Investment in Precision Oncology and Companion Diagnostics Accelerates Genetic Biomarker Discovery
  • OEM Integration of AI and Bioinformatics in Genetic Analysis Enhances Interpretation Accuracy and Clinical Relevance
  • Demand for Preimplantation and Prenatal Genetic Testing Grows in Line with Advancements in Reproductive Health
  • Growth in Consumer Genomics and Direct-to-Consumer Testing Platforms Spurs Market Awareness and Uptake
  • Expansion of Pharmacogenomics in Drug Development Supports Broader Adoption in Clinical Trials
  • Integration of Epigenetic and Transcriptomic Analysis Expands Multi-Omics Research Scope
  • OEM Partnerships with Biopharma Companies Strengthen Validation of Genetic Biomarkers for Drug Targeting
  • Rising Role of Genetic Analysis in Rare Disease Diagnosis Enhances Access to Precision Healthcare Solutions
  • Healthcare Payer Support and Reimbursement for Genetic Tests Drives Broader Adoption in Clinical Settings
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Genetic Analysis Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Genetic Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Next-Generation Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Next-Generation Sequencing Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Next-Generation Sequencing Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Real-Time PCR System Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Real-Time PCR System Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Real-Time PCR System Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Genetic Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Genetic Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Genetic Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cardiovascular Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Cardiovascular Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Rare Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Rare Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Rare Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Infectious Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Infectious Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Research & Development Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Research & Development Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Research & Development Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: World 15-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 50: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 53: World Recent Past, Current & Future Analysis for Predictive Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 54: World Historic Review for Predictive Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: World 15-Year Perspective for Predictive Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 56: World Recent Past, Current & Future Analysis for Carrier Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 57: World Historic Review for Carrier Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: World 15-Year Perspective for Carrier Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 59: World Recent Past, Current & Future Analysis for Prenatal & Newborn Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 60: World Historic Review for Prenatal & Newborn Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: World 15-Year Perspective for Prenatal & Newborn Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 62: World Recent Past, Current & Future Analysis for Disease Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 63: World Historic Review for Disease Diagnostic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: World 15-Year Perspective for Disease Diagnostic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 65: World Recent Past, Current & Future Analysis for Pharmacogenomic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 66: World Historic Review for Pharmacogenomic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: World 15-Year Perspective for Pharmacogenomic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 68: World Recent Past, Current & Future Analysis for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: World Historic Review for Other Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: World 15-Year Perspective for Other Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 71: USA Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: USA Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: USA 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 74: USA Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: USA Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: USA 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 77: USA Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: USA Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: USA 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 80: USA Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: USA Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: USA 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 83: USA Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: USA Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: USA 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 86: Canada Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Canada Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Canada 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 89: Canada Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Canada Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Canada 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 92: Canada Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Canada Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Canada 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 95: Canada Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Canada Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Canada 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 98: Canada Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Canada Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Canada 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• JAPAN
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 101: Japan Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Japan Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Japan 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 104: Japan Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Japan Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Japan 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 107: Japan Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Japan Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Japan 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 110: Japan Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Japan Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Japan 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 113: Japan Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Japan Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Japan 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• CHINA
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 116: China Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: China Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: China 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 119: China Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: China Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: China 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 122: China Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: China Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: China 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 125: China Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: China Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: China 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 128: China Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: China Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: China 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• EUROPE
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 131: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 132: Europe Historic Review for Genetic Analysis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Europe 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 134: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Europe Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Europe 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 137: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Europe Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Europe 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 140: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Europe Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Europe 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 143: Europe Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Europe Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Europe 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 146: Europe Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Europe Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Europe 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• FRANCE
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 149: France Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: France Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: France 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 152: France Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: France Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: France 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 155: France Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: France Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: France 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 158: France Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: France Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: France 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 161: France Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: France Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: France 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• GERMANY
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 164: Germany Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Germany Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Germany 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 167: Germany Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Germany Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Germany 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 170: Germany Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Germany Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Germany 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 173: Germany Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Germany Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Germany 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 176: Germany Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Germany Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Germany 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 179: Italy Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Italy Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Italy 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 182: Italy Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Italy Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Italy 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 185: Italy Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Italy Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Italy 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 188: Italy Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Italy Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Italy 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 191: Italy Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Italy Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Italy 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 194: UK Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UK Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: UK 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 197: UK Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: UK Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: UK 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 200: UK Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: UK Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: UK 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 203: UK Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: UK Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: UK 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 206: UK Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: UK Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: UK 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 209: Spain Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Spain Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Spain 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 212: Spain Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Spain Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Spain 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 215: Spain Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Spain Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Spain 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 218: Spain Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Spain Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Spain 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 221: Spain Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Spain Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Spain 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 224: Russia Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Russia Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Russia 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 227: Russia Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Russia Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Russia 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 230: Russia Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Russia Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Russia 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 233: Russia Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Russia Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Russia 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 236: Russia Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Russia Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Russia 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 239: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Europe Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Europe 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Europe Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Europe 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Europe Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Europe 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Europe Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Europe 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Europe Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Europe Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Europe 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 254: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Asia-Pacific Historic Review for Genetic Analysis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Asia-Pacific 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 257: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Asia-Pacific Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Asia-Pacific 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 260: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Asia-Pacific Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Asia-Pacific 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 263: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Asia-Pacific Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Asia-Pacific 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 266: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Asia-Pacific Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Asia-Pacific 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 269: Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Asia-Pacific Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Asia-Pacific 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 272: Australia Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Australia Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Australia 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 275: Australia Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Australia Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Australia 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 278: Australia Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Australia Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Australia 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 281: Australia Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Australia Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Australia 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 284: Australia Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Australia Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Australia 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• INDIA
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 287: India Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: India Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: India 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 290: India Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: India Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: India 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 293: India Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: India Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: India 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 296: India Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: India Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: India 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 299: India Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: India Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: India 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 302: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: South Korea Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: South Korea 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 305: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: South Korea Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: South Korea 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 308: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: South Korea Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: South Korea 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 311: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: South Korea Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: South Korea 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 314: South Korea Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: South Korea Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: South Korea 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 317: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Asia-Pacific Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 320: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Asia-Pacific Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 323: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Rest of Asia-Pacific Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 326: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Rest of Asia-Pacific Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 329: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Rest of Asia-Pacific Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Rest of Asia-Pacific 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 332: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 333: Latin America Historic Review for Genetic Analysis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Latin America 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 335: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Latin America Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Latin America 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 338: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Latin America Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Latin America 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 341: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Latin America Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Latin America 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 344: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Latin America Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Latin America 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 347: Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Latin America Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Latin America 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 350: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Argentina Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Argentina 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 353: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Argentina Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Argentina 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 356: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Argentina Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Argentina 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 359: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Argentina Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Argentina 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 362: Argentina Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Argentina Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: Argentina 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 365: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Brazil Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: Brazil 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 368: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Brazil Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: Brazil 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 371: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Brazil Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Brazil 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 374: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Brazil Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Brazil 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 377: Brazil Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Brazil Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Brazil 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 380: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Mexico Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Mexico 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 383: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Mexico Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Mexico 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 386: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Mexico Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Mexico 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 389: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Mexico Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Mexico 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 392: Mexico Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Mexico Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Mexico 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 395: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Latin America Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Rest of Latin America 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 398: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Rest of Latin America Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 400: Rest of Latin America 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 401: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Rest of Latin America Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 403: Rest of Latin America 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 404: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Rest of Latin America Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 406: Rest of Latin America 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 407: Rest of Latin America Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Rest of Latin America Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 409: Rest of Latin America 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 410: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 411: Middle East Historic Review for Genetic Analysis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 412: Middle East 15-Year Perspective for Genetic Analysis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 413: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 414: Middle East Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 415: Middle East 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 416: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 417: Middle East Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 418: Middle East 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 419: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 420: Middle East Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 421: Middle East 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 422: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 423: Middle East Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 424: Middle East 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 425: Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 426: Middle East Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 427: Middle East 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 428: Iran Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 429: Iran Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 430: Iran 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 431: Iran Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 432: Iran Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 433: Iran 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 434: Iran Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 435: Iran Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 436: Iran 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 437: Iran Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 438: Iran Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 439: Iran 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 440: Iran Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 441: Iran Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 442: Iran 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 443: Israel Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 444: Israel Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 445: Israel 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 446: Israel Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 447: Israel Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 448: Israel 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 449: Israel Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 450: Israel Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 451: Israel 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 452: Israel Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 453: Israel Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 454: Israel 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 455: Israel Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 456: Israel Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 457: Israel 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 458: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 459: Saudi Arabia Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 460: Saudi Arabia 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 461: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 462: Saudi Arabia Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 463: Saudi Arabia 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 464: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 465: Saudi Arabia Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 466: Saudi Arabia 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 467: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 468: Saudi Arabia Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 469: Saudi Arabia 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 470: Saudi Arabia Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 471: Saudi Arabia Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 472: Saudi Arabia 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 473: UAE Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 474: UAE Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 475: UAE 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 476: UAE Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 477: UAE Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 478: UAE 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 479: UAE Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 480: UAE Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 481: UAE 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 482: UAE Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 483: UAE Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 484: UAE 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 485: UAE Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 486: UAE Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 487: UAE 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 488: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 489: Rest of Middle East Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 490: Rest of Middle East 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 491: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 492: Rest of Middle East Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 493: Rest of Middle East 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 494: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 495: Rest of Middle East Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 496: Rest of Middle East 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 497: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 498: Rest of Middle East Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 499: Rest of Middle East 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 500: Rest of Middle East Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 501: Rest of Middle East Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 502: Rest of Middle East 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030
• AFRICA
  • Genetic Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 503: Africa Recent Past, Current & Future Analysis for Genetic Analysis by Product - Reagents & Kits, Instruments and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 504: Africa Historic Review for Genetic Analysis by Product - Reagents & Kits, Instruments and Software Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 505: Africa 15-Year Perspective for Genetic Analysis by Product - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software for the Years 2015, 2025 & 2030
  • TABLE 506: Africa Recent Past, Current & Future Analysis for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 507: Africa Historic Review for Genetic Analysis by Technology - Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 508: Africa 15-Year Perspective for Genetic Analysis by Technology - Percentage Breakdown of Value Sales for Next-Generation Sequencing Technology, Real-Time PCR System Technology and Other Technologies for the Years 2015, 2025 & 2030
  • TABLE 509: Africa Recent Past, Current & Future Analysis for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 510: Africa Historic Review for Genetic Analysis by Application - Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 511: Africa 15-Year Perspective for Genetic Analysis by Application - Percentage Breakdown of Value Sales for Cancer Application, Genetic Diseases Application, Cardiovascular Diseases Application, Rare Diseases Application, Infectious Diseases Application and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 512: Africa Recent Past, Current & Future Analysis for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 513: Africa Historic Review for Genetic Analysis by End-Use - Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 514: Africa 15-Year Perspective for Genetic Analysis by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research & Development Laboratories End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • TABLE 515: Africa Recent Past, Current & Future Analysis for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 516: Africa Historic Review for Genetic Analysis by Test - Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 517: Africa 15-Year Perspective for Genetic Analysis by Test - Percentage Breakdown of Value Sales for Predictive Genetic Testing, Carrier Testing, Prenatal & Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing and Other Tests for the Years 2015, 2025 & 2030

IV. COMPETITION